TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/8/23 19:35 | 2/6/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lloyd-Smith Malcolm | CA | O | Chief In | S.m | -1,572 | 102.64 | 0 | -15 | -27 | 42 | D | ||||||||||||||
2/2/23 17:24 | 1/31/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lloyd-Smith Malcolm | CA | O | Chief In | S | -183 | 110.02 | 0 | -2 | -6 | 29 | D | ||||||||||||||
8/16/22 18:44 | 8/12/22 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lloyd-Smith Malcolm | CA | O | Chief Re | S.d | -2,281 | 105.95 | 0 | -22 | -44 | 27 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |